Xylo Bio
Boulder
About Xylo Bio
Xylo Bio is a drug development company that focuses on next-generation psychedelics. With psychedelic molecules as the starting point, our goal is to develop medicines that are widely available as improved treatments to currently available SSRI medications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $15.0M
- Funding stage: Seed
- Last round: Grant (Oct 2024)
- Website: xylo.bio
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/xylo-bio-45663 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.